Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: A prospective cohort study

Epidemiology and Infection

Volumn 760, Issue , 2014, Pages

  Arnedo Pena, A ^a,b   Juan Cerdan J V ^c   Romeu Garcia M A ^a   Garcia Ferrer D ^c   Holguin Gomez R ^d   Iborra Millet, J ^c   Pardo Serrano, F ^c  

^a Public Health Center   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^d HOSPITAL DE LA PLANA   (Spain)

Author keywords

Interferon gamma release assay; latent tuberculosis infection; prospective cohort study; tuberculin skin test; tuberculosis; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; INCIDENCE; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SPUTUM EXAMINATION; TUBERCULIN TEST; VITAMIN BLOOD LEVEL; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; FEMALE; IMMUNOLOGY; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RISK FACTOR; TRANSMISSION; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; VITAMIN D DEFICIENCY;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84929171181     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814002386     Document Type: Article

References (39)

1. Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985; 40: 187-190
2. Nnoaham K, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-Analysis. International Journal of Epidemiology 2008; 37: 113-119
3. Gibney KB, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from Sub-Saharan Africa. Clinical Infectious Diseases 2008; 46: 443-446
4. Ho-Pham L, et al. Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infectious Diseases 2010; 10: 306
5. Wejse C, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebocontrolled trial. American Journal Respiratory Critical Care Medicine 2009; 179: 843-850
6. Martineau AR, et al. High-dose vitamin D (3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250
7. Salahuddin N, et al. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infectious Diseases 2013; 13: 22.
8. Ralph AP, et al. L-Arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, placebo-controlled trial. PLoS ONE 2013; 8: e70032
9. Nielsen NO, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a casecontrol study in Greenland. British Journal of Nutrition 2010; 104: 1487-1491
10. Mack U, et al. LTBI: latent tuberculosis infection or lasting immune response to M. tuberculosis? A TBNET consensus statement. European Respiratory Journal 2009; 33: 956-973
11. Bailey WC, et al. Predictive model to identify positive tuberculosis skin test results during contact investigations. Journal of the American Medical Association 2002; 287: 996-1002
12. Arnedo-Pena A, et al. Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infectious Diseases 2011; 11: 349.
13. Ganmaa D, et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-Age children: a randomized, double-blind, placebo-controlled feasibility trial. American Journal of Clinical Nutrition 2012; 96: 391-396
14. Task Group on Tuberculosis. National consensus on the control of tuberculosis in spain. Medicina Clinica (Barcelona) 1992; 98: 24-31
15. Zwerling A, et al. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability. PLoS ONE 2013: 8: e54748
16. Gran G, Abmus J, Dyrhol-Riise AM. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results. BMC Public Health 2013; 13: 353.
17. Cluse ZN, et al. Evaluation of 25-hidroxy vitamin D assay on the immunodiagnostic systems iSYS analyser. Annals Clinical Biochemistry 2012; 49: 159-165
18. Holick MF.Vitamin D deficiency. New England Journal of Medicine 2007; 357: 266-281
19. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. American Journal of Public Health 1998: 88: 15-19
20. Talat N, et al. Vitamin D deficiency and tuberculosis progression. Emerging Infectious Diseases 2010; 16: 853-855
21. Sudfeld C, et al. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. Journal of Infectious Diseases 2013; 207: 378-385
22. Wingfield T, et al. The seasonality of tuberculosis, sunlight, vitamin D, and household crowding. Journal of Infectious Diseases. Published online: 4 March 2014. doi:10.1093/injdis/jiu121
23. Rosen CJ. Vitamin D insufficiency. New England Journal of Medicine 2011; 364: 248-254
24. Aloia J. Clinical Review: The 2011 report on dietary reference intake for vitamin D: Where do we go from here? Journal of Clinical Endocrinology and Metabolism 2011; 96: 2897-2996
25. Dini C, Bianchi A. The potential role of vitamin D for the prevention and treatment of tuberculosis and infectious diseases. Annali dellIstituto Superiore di Sanit 2012; 48: 319-327
26. Hewison M. Antibacterial effects of Vitamin D. Nature Reviews Endocrinology 2011; 7: 337-345
27. Liu PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773
28. Fabri M, et al. Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Science Translational Medicine 2011; 3: 104ra102
29. Liu PT, et al. Convergence of IL-1β and VDR activation pathways in humans TLR 2/1 induced antimicrobial responses. PLoS ONE 2009; 4: e5810
30. Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. Journal of Immunology 2010; 185: 15-22
31. Greenstein RJ, Su L, Brown ST. Vitamins A and D inhibit the growth of Mycobacteria in radiometric culture. PLoS ONE 2012; 7: e29631.
32. Fox GJ, et al. Contact investigation for tuberculosis: a systematic review and meta-Analysis. European Respiratory Journal 2013; 41: 140-156
33. Cailleaux-Cezar M, et al. Tuberculosis incidence among contacts of active pulmonary tuberculosis. International Journal of Tuberculosis and LungDisease 2009; 13: 190-195
34. Goris-Pereiras A, et al. Factors predicting new tuberculosis infections and tuberculin conversions in a contact tracing system. Enfermera Clinica 2008; 18: 183-189
35. Hill P, et al. Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS ONE 2007; 1: e183.
36. Farrell CJ, et al. State-of-Art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clinical Chemistry 2012; 58: 531-542
37. Nienhaus A, et al. IFN-γ release assay versus tuberculin skin test formonitoring TB infection inhealthcareworkers. Expert Review of Anti-Infective Therapy 2013; 11: 37-48
38. Van Zyl-Smit RN, et al. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 2009; 4: e8517
39. Verrall AJ, et al. Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology 2014; 141: 506-513.